Newman presents evidence that direct contracting can lower healthcare costs, improve transparency, and return savings to workers.

More than 1,400 patients enrolled across 9 clinical sites; analytical performance testing included 27 individual studies and over 10,000 PCR test cup runs.

Project designed to support supply chain continuity for customers relying on the company for their cell culture needs.

The new molecular panels are designed to detect up to 22 pathogens in one hour with enhanced norovirus detection.

Alzheimer’s disease is one of the world’s most pressing health challenges, affecting more than 55 million people globally; a number expected to nearly triple by 2050.

Collaboration strengthens Ratio’s long-term isotope supply strategy for clinical development and future pipeline growth.

SkinTE® would be the first new biologic commercially available in the U.S. for the treatment of a common chronic wound indication in nearly 30 years, if approved.

Landmark study of 2,470 patients across two U.S. health systems demonstrates sustained risk-stratified improvements in kidney function, increases in guideline-directed therapy uptake, and – for the first time – measurable reduction in individual patient risk trajectories over 24 months